**An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin** This study looks at how safe and effective a drug called cebranopadol is for treating acute pain, which is sudden pain that can come from surgery or injuries. **Acute pain** is pain that usually starts suddenly and can be severe. **Cebranopadol** is a medication that might help reduce this kind of pain. People who can join the study are adults aged 18 to 75 who are dealing with moderate to severe pain due to surgery or a musculoskeletal condition, which affects muscles and bones. They need a pain score of 4 or more on a 0 to 10 scale, where 0 means no pain and 10 means the worst pain imaginable. People cannot join if they have ongoing pain needing regular medication, certain medical or mental health issues, or a history of substance misuse. Pregnant or breastfeeding women are also excluded. **Key Points:** - Participants must be available for the duration of the study, which requires following strict guidelines. - The study involves taking cebranopadol and may include other allowed pain medications. - There might be risks like side effects or interactions with other medications.

Note: Always talk to your doctor to understand if joining this study is right for you.